BMO Capital Markets initiated coverage on shares of Cigna Corporation (NYSE:CI) in a report released on Monday. The firm issued a market perform rating and a $210.00 price target on the health services provider’s stock.

Several other equities analysts also recently issued reports on CI. Wells Fargo & Company reissued a market perform rating and set a $174.00 price objective (up previously from $163.00) on shares of Cigna Corporation in a research note on Monday, June 19th. Royal Bank Of Canada upped their price objective on shares of Cigna Corporation from $177.00 to $182.00 and gave the company an outperform rating in a research note on Thursday, June 22nd. UBS AG reissued a buy rating and set a $193.00 price objective (up previously from $186.00) on shares of Cigna Corporation in a research note on Thursday, June 22nd. Bank of America Corporation upped their price objective on shares of Cigna Corporation from $193.00 to $198.00 and gave the company a buy rating in a research note on Friday, June 23rd. Finally, Deutsche Bank AG upped their price objective on shares of Cigna Corporation from $175.00 to $180.00 and gave the company a buy rating in a research note on Thursday, July 13th. Two research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of Buy and an average price target of $193.44.

Cigna Corporation (NYSE CI) traded up 1.527% during mid-day trading on Monday, reaching $187.815. 420,540 shares of the company’s stock were exchanged. The stock has a market capitalization of $47.29 billion, a PE ratio of 21.670 and a beta of 0.43. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $193.00. The firm’s 50-day moving average is $185.32 and its 200 day moving average is $170.46.

Cigna Corporation (NYSE:CI) last announced its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.43. The business had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.98 earnings per share. Analysts forecast that Cigna Corporation will post $10.03 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Cigna Corporation (CI) Now Covered by Analysts at BMO Capital Markets” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://www.dailypolitical.com/2017/10/17/cigna-corporation-ci-now-covered-by-analysts-at-bmo-capital-markets.html.

In other news, insider Matthew G. Manders sold 24,357 shares of the stock in a transaction on Friday, July 21st. The shares were sold at an average price of $175.01, for a total value of $4,262,718.57. Following the completion of the sale, the insider now owns 46,256 shares of the company’s stock, valued at $8,095,262.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jane E. Md Henney sold 600 shares of the stock in a transaction on Monday, July 24th. The stock was sold at an average price of $174.14, for a total transaction of $104,484.00. The disclosure for this sale can be found here. Insiders have sold 70,653 shares of company stock valued at $12,437,684 in the last ninety days. 1.30% of the stock is currently owned by company insiders.

Several institutional investors have recently added to or reduced their stakes in the company. Guardian Life Insurance Co. of America increased its position in shares of Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after acquiring an additional 7 shares in the last quarter. Wetherby Asset Management Inc. increased its position in shares of Cigna Corporation by 0.8% in the second quarter. Wetherby Asset Management Inc. now owns 4,192 shares of the health services provider’s stock worth $702,000 after acquiring an additional 33 shares in the last quarter. Cadence Capital Management LLC increased its position in shares of Cigna Corporation by 0.3% in the second quarter. Cadence Capital Management LLC now owns 9,598 shares of the health services provider’s stock worth $1,607,000 after acquiring an additional 33 shares in the last quarter. Winslow Evans & Crocker Inc. increased its position in shares of Cigna Corporation by 1.9% in the second quarter. Winslow Evans & Crocker Inc. now owns 1,814 shares of the health services provider’s stock worth $304,000 after acquiring an additional 34 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. increased its position in shares of Cigna Corporation by 2.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,760 shares of the health services provider’s stock worth $295,000 after acquiring an additional 40 shares in the last quarter. 87.95% of the stock is owned by institutional investors.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Analyst Recommendations for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.